Chemoradiation with gemcitabine for cervical cancer in patients with renal failure
Authors:
- Lesbia RiveraLRLesbia Rivera
- Myrna CandelariaMCMyrna Candelaria
- Jaime de la GarzaJGJaime de la Garza
- Alfonso Dueñas-GonzálezADAlfonso Dueñas-González
- 1 September 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 15 (8) , 761-766
Abstract
The prognosis of cervical cancer patients with renal failure secondary to obstructive uropathy is poor. Our objective was to analyze our experience in the management with chemoradiation of untreated cervical cancer patients complicated by obstructive nephropathy and kidney dysfunction. Untreated patients with cervical cancer and renal failure as manifested by raised serum creatinine were treated with pelvic radiotherapy concurrently with weekly gemcitabine at 300 mg/m2. Response, toxicity and renal function pre- and post-therapy were evaluated. Eight FIGO stage IIIB and one IVB patients were treated. Pre-treatment serum creatinine ranged from 1.6 to 18.5 mg/100 ml (median 3.3, mean 6.8) and creatinine clearance varied from 4 to 57 mg/ml/min (median 17, mean 22.1). Four patients had a percutaneous nephrostomy placed and four patients had symptoms from kidney failure. All patient completed chemoradiation. Most patients had grade 3 leukopenia and neutropenia. Dermatitis, colitis and proctitis were common. All patients had improvement in creatinine clearance (pre-therapy 22.78, post-therapy 54.3 mg/ml/min) (p=0.0058) and all but one normalized serum creatinine. Eight (89%) of nine patients achieved complete response and one patient had persistence. At a median follow-up of 11 months (range 6–14), all patients are alive, one with pelvic and another with systemic disease. Ureteral obstruction causing any degree of renal insufficiency should not be a contraindication to receive chemoradiation to attempt cure. In this setting where cisplatin-based therapy is contraindicated, the use of gemcitabine may be considered.Keywords
This publication has 27 references indexed in Scilit:
- Modern management of locally advanced cervical carcinomaCancer Treatment Reviews, 2003
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Outcome of palliative urinary diversion in the treatment of advanced malignanciesCancer, 1999
- Prognostic significance of ureteral obstruction in primary cervical cancerInternational Journal of Gynecology & Obstetrics, 1994
- Prognostic factors in advanced stage squamous cell cancer of the cervixCancer, 1993
- Untreated cervical cancer complicated by obstructive uropathy and oliguric renal failureGynecologic Oncology, 1981
- Palliative urinary diversion in patients with advanced pelvic malignancyCancer, 1980
- Palliative Urinary Diversion for Pelvic MalignancyJournal of Urology, 1975
- Palliative urinary diversion in patients with advanced carcinoma of the cervixCancer, 1967